LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 38.95 | 770.25 | 4002 | 4543 | 0.8808 | 0.9032 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 38.95 | 770.25 | 4458 | 4543 | 0.9811 | 0.9852 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 41.17 | 770.25 | 4357 | 5010 | 0.8696 | 0.8992 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 41.17 | 770.25 | 4897 | 5010 | 0.9773 | 0.9831 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 43.39 | 770.25 | 4786 | 5404 | 0.8856 | 0.9154 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 43.39 | 770.25 | 5364 | 5404 | 0.9925 | 0.9947 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 45.61 | 770.25 | 5194 | 5813 | 0.8935 | 0.9242 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 45.61 | 770.25 | 5698 | 5813 | 0.9802 | 0.9863 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 47.83 | 770.25 | 5521 | 6223 | 0.8871 | 0.9221 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 47.83 | 770.25 | 6145 | 6223 | 0.9874 | 0.9916 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 50.05 | 770.25 | 6009 | 6629 | 0.9064 | 0.9377 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 50.05 | 770.25 | 6430 | 6629 | 0.9699 | 0.9804 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.27 | 770.25 | 6264 | 7058 | 0.8874 | 0.9266 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 52.27 | 770.25 | 6857 | 7058 | 0.9714 | 0.9819 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.49 | 770.25 | 6675 | 7555 | 0.8835 | 0.9262 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 54.49 | 770.25 | 7232 | 7555 | 0.9572 | 0.9736 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.71 | 770.25 | 7013 | 8001 | 0.8765 | 0.9234 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 56.71 | 770.25 | 7773 | 8001 | 0.9714 | 0.9829 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.94 | 770.25 | 7545 | 8444 | 0.8935 | 0.9359 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 58.94 | 770.25 | 8182 | 8444 | 0.9689 | 0.9818 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 61.16 | 770.25 | 7823 | 8892 | 0.8798 | 0.9287 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 61.16 | 770.25 | 8599 | 8892 | 0.9671 | 0.9811 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 63.39 | 770.25 | 8152 | 9326 | 0.8741 | 0.9266 | MN20160304_L02 | G05 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 63.39 | 770.25 | 9120 | 9326 | 0.9779 | 0.9876 | MN20160304_L02 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 65.61 | 770.25 | 8508 | 9736 | 0.8739 | 0.9277 | MN20160304_L02 | G05 |